Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about TC Biopharm Recent news which mentions TC Biopharm 3 Patients Already Dosed In TC BioPharm's Phase 2b Trial Of A Cutting Edge T Cell Therapy For Hard-to-Treat Cancers January 26, 2023 Tickers TCBP Tags Penny Stocks Benzinga Market News From Benzinga TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia November 22, 2022 Tickers TCBP TCBPW Tags Market News TC Biopharm Penny Stocks From Benzinga Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved November 22, 2022 Tickers ACET BMY IPSC TAK Tags Market News TC Biopharm TAK From Benzinga TC BioPharm Says It Aims To Deliver A Big Breakthrough In Cancer Treatments August 08, 2022 Tickers BMY TCBP TECH Tags News Rumors Biotech From Benzinga TC BioPharm Reports Racing Toward What Could Be A Major Cancer Immunotherapy Breakthrough June 02, 2022 Tickers BLUE TCBP Tags General TCBP Partner Content From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.